Active Ingredient: BENDAMUSTINE HYDROCHLORIDE
Proprietary Name: BENDEKA
Dosage Form; Route of Administration: SOLUTION; IV (INFUSION)
Strength: 100MG/4ML (25MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208194
Product Number: 001
Approval Date: Dec 7, 2015
Applicant Holder Full Name: EAGLE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
